1
|
Toriola AT and Colditz GA: Trends in
breast cancer incidence and mortality in the United States:
Implications for prevention. Breast Cancer Res Treat. 138:665–673.
2013.PubMed/NCBI View Article : Google Scholar
|
2
|
Cardoso F, Paluch-Shimon S, Senkus E,
Curigliano G, Aapro MS, André F, Barrios CH, Bergh J, Bhattacharyya
GS, Biganzoli L, et al: 5th ESO-ESMO international consensus
guidelines for advanced breast cancer (ABC 5). Ann Oncol.
31:1623–1649. 2020.PubMed/NCBI View Article : Google Scholar
|
3
|
Pagani O, Senkus E, Wood W, Colleoni M,
Cufer T, Kyriakides S, Costa A, Winer EP and Cardoso F: ESO-MBC
Task Force. International guidelines for management of metastatic
breast cancer: Can metastatic breast cancer be cured? J Natl Cancer
Inst. 102:456–463. 2010.PubMed/NCBI View Article : Google Scholar
|
4
|
Cardoso F, Spence D, Mertz S,
Corneliussen-James D, Sabelko K, Gralow J, Cardoso MJ, Peccatori F,
Paonessa D, Benares A, et al: Global analysis of
advanced/metastatic breast cancer: Decade report (2005-2015).
Breast. 39:131–138. 2018.PubMed/NCBI View Article : Google Scholar
|
5
|
Firmino F, Villela-Castro DL, Santos JD
and Conceição de Gouveia Santos VL: Topical management of bleeding
from malignant wounds caused by breast cancer: A systematic review.
J Pain Symptom Manage. 61:1278–1286. 2021.PubMed/NCBI View Article : Google Scholar
|
6
|
Maida V, Ennis M, Kuziemsky C and Trozzolo
L: Symptoms associated with malignant wounds: A prospective case
series. J Pain Symptom Manage. 37:206–211. 2009.PubMed/NCBI View Article : Google Scholar
|
7
|
Firmino F, Santos J, Meira KC, de Araújo
JL, Júnior VA and de Gouveia Santos VLC: Regenerated oxidised
cellulose versus calcium alginate in controlling bleeding from
malignant breast cancer wounds: Randomised control trial study
protocol. J Wound Care. 29:52–60. 2020.PubMed/NCBI View Article : Google Scholar
|
8
|
Leung JW, Gotway MB and Sickles EA:
Preoperative embolization of vascular phyllodes tumor of the
breast. AJR Am J Roentgenol. 184 (3 Suppl):S115–S117.
2005.PubMed/NCBI View Article : Google Scholar
|
9
|
Atzori G, Diaz R, Gipponi M, Cornacchia C,
Murelli F, Depaoli F, Sparavigna M, Barbero V, Petrocelli F, Pitto
F, et al: A Case of life-threatening bleeding due to a locally
advanced breast carcinoma successfully treated with transcatheter
arterial embolization. Curr Oncol. 30:2187–2193. 2023.PubMed/NCBI View Article : Google Scholar
|
10
|
Giroux MF, Baum RA and Soulen MC:
Chemoembolization of liver metastasis from breast carcinoma. J Vasc
Interv Radiol. 15:289–2891. 2004.PubMed/NCBI View Article : Google Scholar
|
11
|
Buijs M, Kamel IR, Vossen JA, Georgiades
CS, Hong K and Geschwind JF: Assessment of metastatic breast cancer
response to chemoembolization with contrast agent enhanced and
diffusion-weighted MR imaging. J Vasc Interv Radiol. 18:957–963.
2007.PubMed/NCBI View Article : Google Scholar
|
12
|
Lindgaard SC, Brinch CM, Jensen BK,
Nørgaard HH, Hermann KL, Theile S, Larsen FO, Jensen BV, Michelsen
H, Nelausen KM, et al: Hepatic arterial therapy with oxaliplatin
and systemic capecitabine for patients with liver metastases from
breast cancer. Breast. 43:113–119. 2019.PubMed/NCBI View Article : Google Scholar
|
13
|
Li XP, Meng ZQ, Guo WJ and Li J: Treatment
for liver metastases from breast cancer: Results and prognostic
factors. World J Gastroenterol. 11:3782–3787. 2005.PubMed/NCBI View Article : Google Scholar
|
14
|
Altundag K, Altundag O, Aktolga S, Yavas O
and Boruban C: Hormone receptor status of primary tumor as a
prognostic factor in patients with liver metastases from breast
cancer treated with transcatheter arterial chemoembolization. World
J Gastroenterol. 11(7057)2005.PubMed/NCBI View Article : Google Scholar
|
15
|
Takatsuka Y, Yayoi E, Kobayashi T, Aikawa
T and Kotsuma Y: Neoadjuvant intra-arterial chemotherapy in locally
advanced breast cancer: A prospective randomized study. Osaka
Breast Cancer Study Group. Jpn J Clin Oncol. 24:20–25.
1994.PubMed/NCBI
|
16
|
Ma J, Song J, Chen H, Fan C, Xie J and Qi
X: Intra-arterial interventional therapy for inoperable local
advanced breast cancer: A retrospective study. Oncol Lett.
15:1955–1962. 2018.PubMed/NCBI View Article : Google Scholar
|
17
|
Sato K, Inoue K, Saito T, Kai T, Mihara H,
Okubo K, Koh J, Mochizuki H and Tabei T: Saitama Breast Cancer
Clinical Study Group. Multicenter phase II trial of weekly
paclitaxel for advanced or metastatic breast cancer: The Saitama
Breast Cancer Clinical Study Group (SBCCSG-01). Jpn J Clin Oncol.
33:371–376. 2003.PubMed/NCBI View Article : Google Scholar
|
18
|
Fiorentini G, Tsetis D, Bernardeschi P,
Varveris C, Rossi S, Kalogeraki A, Athanasakis E, Dentico P,
Kanellos P, Biancalani M, et al: First-line intra-arterial
chemotherapy (IAC) with epirubicin and mitoxantrone in locally
advanced breast cancer. Anticancer Res. 23:4339–4345.
2003.PubMed/NCBI
|
19
|
Murakami M, Kuroda Y, Nishimura S, Sano A,
Okamoto Y, Taniguchi T, Nakajima T, Kobashi Y and Matsusue S:
Intraarterial infusion chemotherapy and radiotherapy with or
without surgery for patients with locally advanced or recurrent
breast cancer. Am J Clin Oncol. 24:185–191. 2001.PubMed/NCBI View Article : Google Scholar
|
20
|
Kitagawa K, Yamakado K, Nakatsuka A,
Tanaka N, Matsumura K, Takeda K and Kawarada Y: Preoperative
transcatheter arterial infusion chemotherapy for locally advanced
breast cancer (stage IIIb) for down-staging and increase of
resectability. Eur J Radiol. 43:31–36. 2002.PubMed/NCBI View Article : Google Scholar
|
21
|
Shimamoto H, Takizawa K, Ogawa Y,
Yoshimatsu M, Yagihashi K, Okazaki H, Kanemaki Y, Nakajima Y, Ohta
T, Ogata H and Fukuda M: Clinical efficacy and value of
redistributed subclavian arterial infusion chemotherapy for locally
advanced breast cancer. Jpn J Radiol. 29:236–243. 2011.PubMed/NCBI View Article : Google Scholar
|
22
|
Bilbao JI, Rebollo J, Longo JM, Mansilla
F, Muñoz-Galindo L and Vieitez JM: Neoadjuvant intra-arterial
chemotherapy in inflammatory carcinoma of the breast. Br J Radiol.
65:248–251. 1992.PubMed/NCBI View Article : Google Scholar
|